SC12267 (4SC-101)

DRUG2 trials

Sponsors

4SC AG

Conditions

Inflammatory Bowel Disease (IBD)Rheumatoid Arthritis

Phase 2

SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease

CompletedNCT00820365

4SC AGInflammatory Bowel Disease (IBD)

Start: 2009-03-31End: 2011-03-31Updated: 2011-05-18

SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis

CompletedNCT01010581

4SC AGRheumatoid Arthritis

Start: 2009-11-30End: 2011-07-31Updated: 2012-03-01

Related Papers

The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study

Drugs in R&D2019-10-1629 citations

Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study.

2012-10-1653 citations